EU Vaccine Summit: Tensions and Controversies

This chapter examines an upcoming virtual summit among EU leaders aimed at enhancing vaccine rollout and addressing vaccine export controls, particularly in light of conflicts with AstraZeneca. It discusses the disparities in vaccination rates between the EU and other regions, the complexities of post-Brexit relations with Britain, and the implications of potential export bans. The chapter highlights varying perspectives within the EU on the AstraZeneca vaccine, concerns over its acceptance, and the political ramifications surrounding its distribution and public image.